Argentine Registry of Lp(a)
Launched by SCHOOL OF MEDICINE. NATIONAL UNIVERSITY OF CUYO · Mar 5, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Argentine Registry of Lipoprotein(a) (Lp(a)) is an important study aimed at understanding the connections between Lp(a) levels and various health conditions, such as high cholesterol, heart diseases, diabetes, and high blood pressure. Researchers are collecting detailed information about patients, including their age, gender, medical history, and lifestyle factors like smoking and weight. This study also looks at how medications might affect Lp(a) levels and examines genetic factors that could influence cholesterol levels in patients. By gathering this information, the study hopes to uncover new insights that could help improve cardiovascular health and guide personalized treatment options.
To participate in this study, individuals must be adults aged 65 and older with confirmed Lp(a) levels. Those with certain conditions that could affect Lp(a) readings may not be eligible. Participants will be asked to provide various health details and may undergo regular assessments over time. This research is still recruiting, and it aims to create a comprehensive database that will help healthcare providers better understand Lp(a) and its impact on patients' heart health.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: Adult patients with validated Lp(a) values -
- • Exclusion Criteria: Associated pathologies that can increase the Lp(a) value in a non-specific manner
- • -
About School Of Medicine. National University Of Cuyo
The School of Medicine at the National University of Cuyo is a renowned academic institution dedicated to advancing medical education, research, and clinical practice. As a clinical trial sponsor, the School leverages its robust faculty expertise and innovative research capabilities to facilitate cutting-edge studies aimed at improving healthcare outcomes. Committed to ethical standards and scientific integrity, the institution collaborates with various stakeholders to explore new therapeutic approaches and enhance medical knowledge, ultimately contributing to the betterment of patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mendoza, , Argentina
Patients applied
Trial Officials
Pablo Corral, MD
Study Chair
FASTA University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported